View More
Download these slides from a live Webinar to gain expert insight on the rationale for combining PARP inhibitors and AR-directed therapy in mCRPC including the latest evidence from ASCO GU 2021.
Neal D. Shore, MD, FACS
Released: February 19, 2021
This downloadable slide set from a live Webinar explores the rationale for combining PARP inhibitors with different types of agents for advanced prostate cancer, including immunotherapy, targeted agents, and radionuclides, incorporating the latest evidence from ASCO GU 2021.
Charles J. Ryan, MD
Released: February 19, 2021
Download these slides from a live Webinar to review the most recent clinical data on single-agent PARP inhibitors in metastatic castration-resistant prostate cancer
Charles J. Ryan, MD
Released: February 19, 2021
Download this brief summary slideset from a live Webinar to review the rationale for and most recent clinical data on PARP inhibitor combination therapy in metastatic CRPC.
Charles J. Ryan, MD
Neal D. Shore, MD, FACS
Released: March 3, 2021
Contact Clinical Care Options
For customer support please email: customersupport@cealliance.com
Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.